IRIS
BAROCELLI, Elisabetta
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 21.859
AS - Asia 14.157
EU - Europa 11.322
SA - Sud America 1.873
AF - Africa 779
Continente sconosciuto - Info sul continente non disponibili 35
OC - Oceania 13
Totale 50.038
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 21.327
SG - Singapore 4.884
CN - Cina 4.193
VN - Vietnam 2.219
FI - Finlandia 1.997
SE - Svezia 1.754
IE - Irlanda 1.650
IT - Italia 1.546
BR - Brasile 1.481
DE - Germania 1.253
UA - Ucraina 978
HK - Hong Kong 953
FR - Francia 498
ZA - Sudafrica 491
TR - Turchia 481
GB - Regno Unito 420
NL - Olanda 397
BD - Bangladesh 389
CA - Canada 334
IN - India 279
RU - Federazione Russa 197
AR - Argentina 151
BE - Belgio 129
CI - Costa d'Avorio 119
MX - Messico 106
AT - Austria 96
JP - Giappone 92
ES - Italia 89
IQ - Iraq 89
ID - Indonesia 75
PH - Filippine 74
PL - Polonia 64
PK - Pakistan 63
CZ - Repubblica Ceca 62
KR - Corea 61
RO - Romania 60
EC - Ecuador 58
TH - Thailandia 50
CO - Colombia 41
VE - Venezuela 37
PY - Paraguay 34
MA - Marocco 33
EU - Europa 32
TW - Taiwan 30
LT - Lituania 29
CM - Camerun 26
UZ - Uzbekistan 25
CL - Cile 24
EG - Egitto 22
AZ - Azerbaigian 21
KE - Kenya 21
MY - Malesia 21
SA - Arabia Saudita 21
JO - Giordania 20
PA - Panama 19
PE - Perù 16
TN - Tunisia 16
AE - Emirati Arabi Uniti 14
UY - Uruguay 14
ET - Etiopia 13
JM - Giamaica 13
BO - Bolivia 12
CR - Costa Rica 12
NP - Nepal 12
AL - Albania 11
AU - Australia 11
BG - Bulgaria 11
HU - Ungheria 11
IR - Iran 11
DO - Repubblica Dominicana 10
KZ - Kazakistan 10
LB - Libano 10
OM - Oman 10
CH - Svizzera 9
DZ - Algeria 9
IL - Israele 9
HN - Honduras 7
HR - Croazia 7
SI - Slovenia 7
SN - Senegal 7
TT - Trinidad e Tobago 7
BB - Barbados 6
BY - Bielorussia 6
GE - Georgia 6
SC - Seychelles 6
DK - Danimarca 5
EE - Estonia 5
NI - Nicaragua 5
PT - Portogallo 5
QA - Qatar 5
RS - Serbia 5
SV - El Salvador 5
SY - Repubblica araba siriana 5
BH - Bahrain 4
GA - Gabon 4
KG - Kirghizistan 4
LU - Lussemburgo 4
MD - Moldavia 4
PS - Palestinian Territory 4
AO - Angola 3
Totale 49.985
Salva come PNG Salva come JPEG
Città #
Dallas 5.851
Singapore 2.602
Ashburn 1.811
Chandler 1.661
Dublin 1.649
San Jose 1.373
Jacksonville 1.115
Santa Clara 1.056
Beijing 1.000
Ann Arbor 894
Hong Kong 892
Dearborn 768
Ho Chi Minh City 681
Boardman 554
Parma 475
Hanoi 469
Johannesburg 468
Nanjing 428
New York 420
Izmir 398
Los Angeles 353
Princeton 310
Shanghai 309
Munich 294
Lauterbourg 288
Wilmington 213
San Mateo 210
Toronto 191
Hefei 189
Helsinki 178
Bremen 151
Buffalo 148
São Paulo 144
Hebei 133
Kunming 133
Nanchang 132
Shenyang 126
Brussels 125
Jinan 121
Abidjan 119
Moscow 108
Council Bluffs 101
Des Moines 99
Haiphong 97
Guangzhou 94
Frankfurt am Main 92
Columbus 88
Grafing 84
Vienna 83
Woodbridge 83
Tianjin 80
Da Nang 79
Tokyo 78
Chicago 74
Turku 74
Seattle 70
Changsha 64
Jiaxing 63
London 62
Milan 57
Montreal 57
Rio de Janeiro 57
Brooklyn 53
Fremont 53
Houston 52
Bologna 49
Warsaw 48
Hangzhou 42
Orem 42
The Dalles 41
Norwalk 40
Chennai 39
Jakarta 38
Zhengzhou 38
Amsterdam 37
Atlanta 37
Denver 37
Phoenix 36
Ottawa 34
Auburn Hills 33
Modena 33
Belo Horizonte 32
Biên Hòa 31
Nuremberg 31
Poplar 31
Pune 31
Rome 31
Stockholm 31
Brno 30
Manchester 30
Mexico City 30
Boston 29
Hải Dương 29
Marseille 29
Baghdad 28
Redondo Beach 28
Bangalore 27
Can Tho 27
West Jordan 27
Curitiba 26
Totale 31.516
Salva come PNG Salva come JPEG
Nome #
1,8-Naphthyridines IX. Potent anti-inflammatory and/or analgesic activity of a new group of substituted 5 amino[1,2,4]triazolo[4,3-a] [1,8]naphthyridine-6 carboxamides, of some their Mannich base derivatives and of one novel substituted 5-amino-10-oxo-10Hpyrimido[1,2-a [1,8]naphthyridine-6-carboxamide derivative 1.699
1,5-Benzodiazepines Part XIII. Substututed 4H-[1,2,4]triazolo[4,3-a][1,5]benzodiazepin-5-amines and 4H-imidazo-[1,2-a][ 1,5]benzodiazepin-5-amines as analgesic, anti-inflammatory and/or antipyretic agents with low acute toxicity 1.674
1,4-dioxane, a suitable scaffold for the development of novel M3 muscarinic receptor antagonists 1.632
1,5-Benzodiazepin tricyclic derivatives as analgersic, anti-inflammatory and /or antipyretic agents with very low acute gastrolesivity and toxicity 1.619
Targeting the Eph/ephrin system as anti-inflammatory strategy in IBD 253
1,8-Naphthyridines V. Novel N-substituted 5-amino-N,N-diethyl-9-isopropyl [1,2,4]triazolo[4,3-a] [1,8]naphthyridine-6-carboxamides, as potent anti-inflammatory and/or analgesic agents completely devoid of acute gastrolesivity 252
Discovery of a new 1-(phenylsulfonyl)-1H-indole derivative targeting the EphA2 receptor with antiproliferative activity on U251 glioblastoma cell line 251
Pharmacological characterization of second generation FXR agonists as effective EphA2 antagonists: A successful application of target hopping approach 251
Excipient-free pulmonary insulin dry powder: Pharmacokinetic and pharmacodynamics profiles in rats 247
Inhibition of Eph/ephrin interaction with the small molecule UniPR500 improves glucose tolerance in healthy and insulin-resistant mice 243
Polymeric films loaded with cisplatin for malignant pleural mesothelioma: a pharmacokinetic study in an ovine model 234
2-Aminobenzimidazoles as new potent H3-antagonists 224
Pharmacological evaluation of new bioavailable small molecules targeting Eph/ephrin interaction 223
Antiplatelet and antithrombotic activities of essential oil from wild Ocotea quixos (Lam.) Kosterm. (Lauraceae) calices from Amazonian Ecuador 219
Amino acid conjugates of lithocholic acid as antagonists of the EphA2 receptor. 219
3D-printed chitosan-based scaffolds: An in vitro study of human skin cell growth and an in-vivo wound healing evaluation in experimental diabetes in rats 218
Development of an orally bioavailable small molecule targeting Eph-ephrin system: in vitro and in vivo anticancer activity. 217
A promising imidazole-free histamine H3 receptor antagonist with good brain penetration and anticholinesterase activity. 213
Increased Mucosal Thrombin is Associated with Crohn's Disease and Causes Inflammatory Damage through Protease-activated Receptors Activation 209
Dibasic biphenyl H(3) receptor antagonists: Steric tolerance for a lipophilic side chain. 208
Bifidobacterium bifidum PRL2010 alleviates intestinal ischemia/reperfusioni injury 208
Enteric dysfunctions in experimental Parkinson's disease: alterations of excitatory cholinergic neurotransmission regulating colonic motility in rats 206
Combined hyaluronate-based films loaded with pemetrexed and cisplatin for the treatment of malignant pleural mesothelioma: Preliminary evaluation in an orthotopic tumor recurrence model 205
Antinociceptive and gastroprotective effects of inhaled and orally administered Lavandula hybrida Reverchon “Grosso” essential oil 203
Discovery and development of Eph-ephrin antagonists endowed with antiangiogenic properties 202
Amino acid derivatives as palmitoylethanolamide prodrugs: Synthesis, in vitro metabolism and in vivo plasma profile in rats 201
Analgesic properties of benzisothiazole/ benzimidazole derivatives with acidic groups 199
Synthesis, biological activity, QSAR and QSPR study of 2/aminobenzimidazole derivatives as potent H3-antagonists 198
UniPR129 is a competitive small molecule Eph-ephrin antagonist blocking in vitro angiogenesis at low micromolar concentrations. 197
Third generation EGFR inhibitor osimertinib combined with pemetrexed or cisplatin exerts long-lasting anti-tumor effect in EGFR-mutated pre-clinical models of NSCLC 197
Comparison of the effects of structurally different H2-antagonists on acid and pepsin activity stimulated by dimaprit in conscious cats 196
Aminobenzimidazoles as new potent H3-antagonists 196
Protective Effects of a Protease Inhibitor (Gabexate Mesilate) on Intestinal Ischemia/Reperfusion Injury in Rats 194
1,8-Naphthyridines VII. New substituted 5-amino[1,2,4]triazolo[4,3-a][1,8]naphthyridine-6-carboxamides and their isosteric analogues, exhibiting notable anti-inflammatory and/or analgesic activities, but no acute gastrolesivity. 193
1,8-Naphthyridines VIII. Novel 5-aminoimidazo[1,2-a] [1,8]naphthyridine-6-carboxamide and 5-amino[1,2,4]triazolo[4,3-a] [1,8]naphthyridine-6-carboxamide derivatives showing potent analgesic or anti-inflammatory activity, respectively, and completely devoid of acute gastrolesivity. 192
Azionifarmacologiche di composti alchilaminoalchilfenilbenzisotiazolici sul trattogastrointestinale 191
Accommodation and peristalsis are functional responses to chronic obstruction in rat hypertrophic ileum 190
Polyphenol rich botanicals used as food supplements interfere with EphA2-ephrinA1 system. 190
2,4-Substituted benzopyrano[4,3-d]pyrimidines and benzopyrano[4,3-d]pyrimidin-5-ones: synthesis and antiplatelet activity 189
[Experimental tracheal transplantation. Literature review and proposal of an original surgical technique]. 186
Impact of S1P mimetics on mesenteric ischemia/reperfusion injury 186
Human colonoid-derived monolayers and Caco-2: comparative analysis of inflammatory responses 185
Enhancement of the anti-tumor activity of FGFR1 inhibition in squamous cell lung cancer by targeting downstream signaling involved in glucose metabolism. 185
2-Amino-1,2-benzisothiazolin-3-one derivatives as powerful antiplatelet agents 185
Design and structure-activity relationship of amino acid derivatives of lithocholic acid as novel EphA2 antagonists 185
The Role of HB-Donor Groups in the Heterocyclic Polar Fragment of H3-Antagonists. I. Synthesis and Biological Assays 183
Combination of Gefitinib and Pemetrexed Prevents the Acquisition of TKI Resistance in NSCLC Cell Lines Carrying EGFR-Activating Mutation 180
Caratterizzazione farmacologica in vitro di nuovi agonisti muscarinici analoghi dell'Oxotremorina 179
Cognition enhancing effect in rats of a selected histamine H3 receptor antagonist with good brain penetration 178
NEW EPH ANTAGONISTS DISCRIMINATING BETWEEN EPH-AS AND EPH-BS CLASSES 177
Validation of a histamine H3 receptor model through structure–activity relationships for classical H3 antagonists 177
Access to CNS of selected H3-antagonists: ex vivo binding study in rats 177
Suppression of inflammatory events associated to intestinal ischemia-reperfusion by 5-HT1A blockade in mice 176
Structure–Activity Relationships and Mechanism of Action of Eph–ephrin Antagonists: Interaction of Cholanic Acid with the EphA2 Receptor 176
Gastrointestinal symptoms and local oxidative stress in a model of Parkinson's Disease in rats 176
Daily assumption of fermented milk containing Bifidobacterium breve 246 B® promotes prophylactic effects against intestinal inflammation in mice 175
4-(1,2-benzisothiazol-3-)alkanoic and phenylalkanoic acids: synthesis and anti-inflammatory, analgesic and antipyretic activities 175
Hake fish bone as a calcium source for efficient bone mineralization 175
Lithocholic acid is an Eph-ephrin ligand interfering with Eph-kinase activation 174
4-(3-Oxo-1,2-benzisothiazolin-2-yl)alkanoic, phenyl and phenoxyalkanoic acids: synthesis and anti-inflammatory, analgesic, and antipyretic properties 173
Combined use of anti-ErbB monoclonal antibodies and erlotinib enhances antibody-dependent cellular cytotoxicity of wild-type erlotinib-sensitive NSCLC cell lines 171
Adaptive changes in rat ileum motility induced by mild mesenteric ischemia/reperfusion injury: role of endogenous mediators and reperfusion time 170
Physicochemical and pharmacokinetic properties of polymeric films loaded with cisplatin for the treatment of malignant pleural mesothelioma 169
270 Discovery, development and optimization of low molecular weight EPH–ephrin protein–protein inhibitors 168
Accommodation and peristalsis are functional responses to obstruction in rat hypertrophic ileum 168
Elucidating the gut microbiome of ulcerative colitis: bifidobacteria as novel microbial biomarkers 168
Histamine H4 receptor antagonism and mesenteric ischemia/reperfusion injury in mice 167
The anti-H1-histaminic and antimuscarinic effect of 2- and 4-[benzyl-(2-dimethylaminoethyl)amino]pyrimidine compounds]. 167
Novel Analgesic Agents Obtained by Molecular Hybridization of Orthosteric and Allosteric Ligands 167
Analgesici-antipiretici benzopirano pirimidinici non acidici attivi per via orale privi di gastrolesività 167
Probing the effects of MR120 in preclinical chronic colitis: A first-in-class anti-IBD agent targeting the CCL20/CCR6 axis 166
A New Potent and Selective Histamine H3-Receptor Antagonist, 4(5)-{2-[4(5)-cyclohexylimidazol-2-ylthio]ethyl}imidazole 165
A preliminary study of engineered nanoparticles effects on barrier function of airway epithelial monolayers 165
1-Methyl and 1-(2-hydroxyalkyl)-5-(3-alkyl/cycloalkyl/phenyl/naphthylureido)-1H-pyrazole-4-carboxylic acid ethyl esters as potent human neutrophil chemotaxis inhibitors 165
UniPR1331: small Eph/ephrin antagonist beneficial in intestinal inflammation by interfering with type-B signaling 165
Dual-Acting Drugs: an in vitro Study of Nonimidazole Histamine H(3) Receptor Antagonists Combining Anticholinesterase Activity 164
Perturbation of The EphA2-EphrinA1 System in Human Prostate Cancer Cells by Colonic (Poly)phenol Catabolites 163
Discovery and development of small molecules targeting Eph-ephrin system in glioblastoma: an academic history 163
2-Amino-1,2-benzisothiazolin-3-one Derivatives: Synthesis and Assessment of their Antiplatelet/Spasmolytic Effects 163
Development of 3-oxo-cholenic derivatives as Eph antagonists able to block in vitro angiogenesis 163
Dibasic non-imidazole histamine H3 receptor antagonists with a rigid byphenyl scaffold. 162
5-HT1A receptors as target to protect the intestine in an experimental model of colitis 162
Intestinal chronic obstruction affects motor responsiveness of rat hypertrophic longitudinal and circular muscles 162
Discovery of small-molecule targeting the CCL20/CCR6 axis as first-in-class inhibitors for inflammatory bowel diseases 161
Dual role of endogenous serotonin in 2,4,6-Trinitrobenzene Sulfonic Acid-induced colitis 161
Comparative screening of plant essential oils: phenylpropanoid moiety as basic core for antiplatelet activity 161
Multiple approaches for the discovery and development of small molecules targeting Eph-ephrin protein-protein interaction 161
Biochemical platform for the identification of adverse effects triggered by free hemoglobin in guinea pigs 160
Analgesic activity of new hybrid muscarinic agonists in mice 160
Antinociceptive affects of inhalated and orally administered Lavandula hybrida Reverchon "Grosso" essential oil 159
Inflammatory proteases released in a mouse model of intestinal ischemia 159
Eph/ephrin targeting with a small molecule improves glucose tolerance in healthy and insulin-resistant mice 159
QSAR study of 2-aminobenzimidazole derivatives as H3 antagonists 159
Anomalous responses to histamine stimulation of guinea-pig oesophageal muscularis mucosae. 158
Antiulcer long-term treatment in chronic ulcer rat 158
Botanicals used as food supplements interfering with EphA2-ephrinA1 system: a screening study 158
5-Alkoxy-2-hydrazino and 5-methoxy-2-amino-5H[1]benzopyrano[4,3-d]pyrimidines: synthesis and pharmacological activity 157
Effect of μ Opioid Receptor Activation On Intestinal Ischemia/Reperfusion Injury in Mice 157
Access to CNS of selected H3-antagonists: ex vivo binding study in rats 156
Biochemical characterization of EphA2 antagonists with improved physico-chemical properties by cell-based assays and surface plasmon resonance analysis 156
Totale 24.325
Salva come PNG Salva come JPEG
Categoria #
all - tutte 154.143
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 154.143
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202178 0 0 0 0 0 0 0 0 0 0 0 78
2021/20221.869 64 57 53 239 117 126 199 213 71 125 116 489
2022/20236.474 760 675 390 473 646 725 111 361 1.997 57 199 80
2023/20242.213 128 194 59 88 168 565 211 119 85 111 160 325
2024/20257.401 229 397 514 411 723 870 281 353 817 690 628 1.488
2025/202621.444 1.559 2.604 5.657 1.642 2.238 965 1.729 564 2.276 1.238 649 323
Totale 50.370